U.S. Physical Therapy (NYSE:USPH) Director Buys $17,712.00 in Stock

U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) Director Peter Francis Minan bought 288 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The shares were acquired at an average price of $61.50 per share, for a total transaction of $17,712.00. Following the acquisition, the director directly owned 3,211 shares of the company’s stock, valued at approximately $197,476.50. The trade was a 9.85% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Peter Francis Minan also recently made the following trade(s):

  • On Monday, June 8th, Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock. The stock was acquired at an average cost of $63.14 per share, with a total value of $31,064.88.

U.S. Physical Therapy Price Performance

NYSE USPH traded up $1.12 on Wednesday, hitting $62.92. 222,611 shares of the company were exchanged, compared to its average volume of 207,326. The firm has a 50 day moving average of $68.81 and a two-hundred day moving average of $76.42. The company has a market cap of $957.63 million, a P/E ratio of 125.84, a P/E/G ratio of 1.69 and a beta of 1.16. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy, Inc. has a 1-year low of $58.19 and a 1-year high of $93.50.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The company had revenue of $198.29 million during the quarter, compared to analyst estimates of $200.94 million. During the same quarter in the previous year, the business posted $0.48 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Friday, May 22nd. U.S. Physical Therapy’s payout ratio is 368.00%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Citizens Jmp dropped their price objective on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research report on Friday, May 8th. Finally, Citigroup restated an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

Read Our Latest Report on USPH

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. William Blair Investment Management LLC acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth $29,381,000. American Century Companies Inc. acquired a new position in U.S. Physical Therapy in the third quarter valued at about $21,940,000. Bahl & Gaynor Inc. boosted its holdings in U.S. Physical Therapy by 47.6% during the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after buying an additional 153,054 shares during the last quarter. Bank of America Corp DE boosted its holdings in U.S. Physical Therapy by 77.2% during the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after buying an additional 138,194 shares during the last quarter. Finally, Schroder Investment Management Group grew its position in shares of U.S. Physical Therapy by 45.9% during the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after buying an additional 114,618 shares during the period.

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Featured Stories

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.